Human Longevity

Human Longevity, Inc. (HLI) is a genomics and cell therapy company focused on extending the healthy, high performance human lifespan. Led by a world-class team of scientific and medical visionaries, HLI’s mission is to identify the therapeutically targetable mechanisms responsible for age-related human biological decline and to apply this intelligence to develop innovative solutions to interrupt or block those processes, meaningfully extending the human lifespan. We are building a database of genotype and phenotype information together with data mining infrastructure, on a scale that has not ever been done before. We are trying to tackle some of the most vexing diseases like cancer, heart disease and diabetes. We are blazing a new trail in science, medicine and research and we need people who, like us, want to change the world. Our founders, along with our scientific and medical teams are impatient for the healthcare of the future. That is why we are working to change the way medicine is practiced through our genomic-focused, preventive model. We are seeking world-class people who share our passion and want to play an integral role in executing the company’s vision. If you are dynamic, innovative, creative, intelligent, and resourceful, consider joining our quest to improve the state of healthcare in the world today.
Type
Private
HQ
San Diego, US
Founded
2013
Employees
264 (est)
Human Longevity was founded in 2013 and is headquartered in San Diego, US

Key People at Human Longevity

Felix Frueh

Felix Frueh

Chief Scientific Officer
J. Craig Venter

J. Craig Venter

Co-Founder, Executive Chairman & CEO
William Biggs

William Biggs

Head, Genomic Sequencing
Brian Berning

Brian Berning

Head, Finance
Steven French

Steven French

Head, Technology Development
Peter Diamandis

Peter Diamandis

Co-Founder

Human Longevity Locations

San Diego, US
San Diego, US
Mountain View, US
Singapore, SG

Human Longevity Metrics

Human Longevity Summary

Founding Date

2013

Total Funding

$290 M

Latest funding size

$220 M

Time since last funding

8 months

Investors

Human Longevity's latest funding round of $220 M was in April 2016. In total, Human Longevity has raised $290 M.

Market Position – Health, data management

Human Longevity Online Presence

Human Longevity News

Human Longevity Company Life

You may also be interested in